Cardiac Pathology

On this page

🔬 Cardiac Pathology: The Heart's Microscopic Battlefield

The heart's relentless work-100,000 beats daily pumping 2,000 gallons of blood-makes it uniquely vulnerable when cellular machinery fails, oxygen supply falters, or immune attacks turn inward. You'll journey from microscopic injury patterns through ischemic crises, inflammatory assaults, and structural failures to master the diagnostic reasoning and treatment algorithms that distinguish competent clinicians from exceptional ones. This lesson builds your ability to recognize cardiac pathology's signatures, understand why each disease unfolds as it does, and intervene with precision when hearts hang in the balance.

Cardiac pathology transforms abstract disease concepts into tangible cellular realities. Every chest pain, every murmur, every heart failure symptom originates from specific microscopic changes that pathologists decode with mathematical precision. Understanding these cellular signatures unlocks the logic behind every cardiac presentation.

Pathological Process Categories

  • Ischemic Disorders (40% of cardiac deaths)

    • Acute coronary syndromes with <6 hour cellular changes
    • Chronic ischemia showing fibrosis >25% of myocardium
      • Subendocardial pattern: inner 1/3 involvement
      • Transmural pattern: full-thickness necrosis
      • Watershed zones: border area vulnerability
  • Cardiomyopathies (25% of heart failure cases)

    • Dilated: >55mm left ventricular end-diastolic diameter
    • Hypertrophic: >15mm septal thickness
      • Asymmetric pattern: septal:posterior wall ratio >1.3:1
      • Symmetric pattern: concentric thickening >13mm
  • Valvular Pathology (15% of cardiac interventions)

    • Stenotic lesions: <1.0 cm² effective orifice area
    • Regurgitant lesions: >40% regurgitant fraction

📌 Remember: CARDIAC pathology classification - Coronary (ischemic), Arrhythmogenic, Restrictive, Dilated, Infiltrative, Acute inflammatory, Congenital. Each category has distinct microscopic signatures with specific timeframes for cellular changes.

Disease CategoryCellular HallmarkTimelineDiagnostic MarkerPrognosisKey Measurement
Acute MICoagulation necrosis6-24 hoursTroponin >50x ULN10% mortality>20% LV involvement
Dilated CMPMyocyte hypertrophyMonths-yearsBNP >400 pg/mL50% 5-year survivalEF <40%
Hypertrophic CMPDisarray + fibrosisYears-decadesSeptal thickness >15mm1% sudden deathGradient >30 mmHg
Restrictive CMPInterstitial fibrosisVariableElevated filling pressuresPoor if advancedE/A ratio >2
MyocarditisLymphocytic infiltrateDays-weeksEndomyocardial biopsy80% recovery>14 cells/mm²

💡 Master This: Every cardiac pathological process creates specific microscopic fingerprints. Ischemia produces coagulation necrosis, inflammation shows lymphocytic infiltrates, and pressure overload generates concentric hypertrophy. Recognition of these patterns enables precise diagnosis within minutes of microscopic examination.

Understanding cardiac pathology's cellular foundation connects directly to recognizing how these microscopic changes manifest as clinical syndromes and guide therapeutic interventions.


🔬 Cardiac Pathology: The Heart's Microscopic Battlefield

⚡ Ischemic Heart Disease: The Oxygen Debt Crisis

Ischemic Cascade Progression

Loading diagram…
  • Acute Coronary Syndromes (1.5 million cases annually)

    • STEMI: complete occlusion with ST elevation >1mm in ≥2 leads
    • NSTEMI: partial occlusion with troponin elevation but no ST elevation
      • High-risk: TIMI score ≥5 with >40% event rate
      • Intermediate-risk: TIMI score 3-4 with 20% event rate
      • Low-risk: TIMI score 0-2 with <5% event rate
  • Chronic Ischemic Disease (stable angina patterns)

    • Effort angina: symptoms with >75% stenosis during exertion
    • Unstable angina: crescendo pattern with plaque rupture risk
      • Class I: recent onset severe angina within 2 months
      • Class II: accelerating angina with increased frequency
      • Class III: rest angina within 48 hours

📌 Remember: TIMELINE for MI evolution - Troponin rises (3-6 hours), Inflammation peaks (24-72 hours), Macrophages arrive (3-7 days), Early granulation (1-2 weeks), Late fibrosis (2-8 weeks), Infarct maturation (2-6 months), New equilibrium (>6 months), Endstage remodeling (years).

⭐ Clinical Pearl: Door-to-balloon time <90 minutes reduces mortality by 25% in STEMI patients. Every 30-minute delay increases 1-year mortality by 7.5%. Troponin elevation >50x upper limit indicates large infarct with >20% left ventricular involvement and doubled mortality risk.

Infarct LocationCoronary TerritoryECG ChangesComplicationsMortality RiskWall Motion
AnteriorLADV1-V6Pump failure15-20%Hypokinesis
InferiorRCAII, III, aVFHeart block5-10%Akinesis
PosteriorLCX/RCAV7-V9Mitral regurg8-12%Dyskinesis
LateralLCXI, aVL, V5-V6Arrhythmias6-8%Aneurysm
RVRCAV1, V4RRV failureVariableTricuspid regurg

Recognizing ischemic patterns establishes the foundation for understanding how inflammatory processes can mimic or complicate coronary disease presentations.


⚡ Ischemic Heart Disease: The Oxygen Debt Crisis

🔥 Inflammatory Cardiac Diseases: The Immune System's Cardiac Assault

Inflammatory Disease Spectrum

  • Myocarditis (1-5% of viral infections)

    • Viral: Coxsackievirus B causes 50% of cases
    • Autoimmune: Giant cell myocarditis with <20% 5-year survival
      • Acute phase: >14 lymphocytes/mm² on endomyocardial biopsy
      • Chronic phase: fibrosis >25% with persistent inflammation
      • Fulminant: cardiogenic shock within <2 weeks of symptoms
  • Pericarditis (viral etiology in 80-90% of cases)

    • Acute: chest pain with friction rub and ST elevation
    • Chronic: >3 months duration with recurrent episodes
      • Constrictive: equalization of diastolic pressures
      • Effusive: >20 mm echo-free space around heart
  • Endocarditis (blood culture positive in 85% of cases)

    • Acute: S. aureus with rapid valve destruction
    • Subacute: Viridans streptococci with indolent course
      • Native valve: mortality 15-25% despite treatment
      • Prosthetic valve: mortality 25-40% with surgical urgency

Loading diagram…

📌 Remember: INFLAME criteria for myocarditis - Infiltrate (lymphocytic), Necrosis (myocyte), Fibrosis (interstitial), Left ventricular dysfunction, Arrhythmias, Markers elevated (troponin), Echocardiographic changes. >14 lymphocytes/mm² confirms diagnosis on endomyocardial biopsy.

Inflammatory DiseasePrimary PathogenDiagnostic CriteriaTreatment DurationMortality RateRecurrence Risk
Viral MyocarditisCoxsackievirus BTroponin + MRI3-6 months5-10%10-15%
Giant Cell MyocarditisAutoimmuneBiopsy requiredLifelong>80%High
Acute PericarditisViral/IdiopathicClinical + ECG2-4 weeks<1%20-30%
Bacterial EndocarditisS. aureusBlood cultures + echo4-6 weeks15-25%5-10%
Constrictive PericarditisPost-surgicalCatheterizationSurgical5-15%Rare

💡 Master This: Inflammatory cardiac diseases create distinct histological signatures. Lymphocytic infiltrates indicate viral myocarditis, giant cells suggest autoimmune disease, and neutrophilic infiltrates point to bacterial infection. Endomyocardial biopsy remains gold standard for myocarditis diagnosis with >95% specificity when >14 lymphocytes/mm² are present.

Understanding inflammatory patterns provides the foundation for recognizing how structural heart diseases develop through different pathophysiological mechanisms.


🔥 Inflammatory Cardiac Diseases: The Immune System's Cardiac Assault

🏗️ Structural Heart Disease: The Architecture Under Siege

Structural Disease Categories

  • Valvular Diseases (2-7% population prevalence)

    • Aortic stenosis: valve area <1.0 cm² with mean gradient >40 mmHg
    • Mitral regurgitation: regurgitant volume >60 mL per beat
      • Degenerative: myxomatous degeneration in 2% of population
      • Functional: annular dilatation with >40 mm diameter
      • Rheumatic: commissural fusion with restricted mobility
  • Cardiomyopathies (1:500 population prevalence)

    • Hypertrophic: septal thickness >15 mm with dynamic obstruction
    • Dilated: ejection fraction <40% with LV diameter >55 mm
      • Ischemic: >75% due to coronary artery disease
      • Non-ischemic: genetic mutations in 40% of cases
      • Toxic: anthracycline-induced with dose-dependent risk
  • Congenital Defects (8 per 1000 live births)

    • Simple: ASD, VSD, PDA with left-to-right shunts
    • Complex: Tetralogy of Fallot with 4 anatomical components
      • Pulmonary stenosis with gradient >50 mmHg
      • Ventricular septal defect >1 cm diameter
      • Overriding aorta with >50% override
      • Right ventricular hypertrophy >15 mm wall thickness
Loading diagram…

📌 Remember: VALVE assessment parameters - Velocity (peak >4 m/s severe AS), Area (effective orifice <1.0 cm² severe), Left ventricular response (hypertrophy >15 mm), Volume overload (regurgitant >60 mL), Ejection fraction (preserved vs reduced). Each parameter has specific thresholds for severity grading.

Structural DiseaseKey MeasurementSevere ThresholdSurgical Indication5-Year SurvivalComplication Rate
Aortic StenosisValve Area<1.0 cm²Symptoms + severe AS>95%<3%
Mitral RegurgitationRegurgitant Volume>60 mLEF <60% or ESD >40mm>90%<5%
Hypertrophic CMPSeptal Thickness>15 mmGradient >50 mmHg>95%<2%
Dilated CMPEjection Fraction<35%Heart failure symptomsVariableVariable
Tetralogy of FallotRV/LV Pressure>0.7Cyanosis or symptoms>90%10-15%

💡 Master This: Structural heart diseases follow predictable remodeling patterns. Pressure overload creates concentric hypertrophy (thick walls, small cavity), while volume overload produces eccentric hypertrophy (thin walls, large cavity). Understanding these geometric adaptations enables precise hemodynamic assessment and optimal timing of surgical interventions.

Recognizing structural patterns establishes the framework for understanding how these anatomical changes create specific clinical presentations requiring targeted diagnostic approaches.


🏗️ Structural Heart Disease: The Architecture Under Siege

🎯 Diagnostic Pattern Recognition: Decoding the Cardiac Clues

Loading diagram…

Clinical Presentation Patterns

  • Chest Pain Syndromes (8 million ED visits annually)

    • Typical angina: substernal pressure with exertional trigger and nitroglycerin relief
    • Atypical angina: 2 of 3 typical characteristics present
      • Location: substernal, left arm, jaw radiation
      • Quality: pressure, squeezing, heaviness sensation
      • Duration: 2-10 minutes with crescendo-decrescendo pattern
      • Triggers: exertion, emotion, cold exposure
  • Heart Failure Presentations (6.5 million Americans affected)

    • Acute decompensation: rapid onset over hours to days
    • Chronic progression: gradual decline over months to years
      • NYHA Class I: no symptoms with ordinary activity
      • NYHA Class II: slight limitation with ordinary activity
      • NYHA Class III: marked limitation with less than ordinary activity
      • NYHA Class IV: symptoms at rest or minimal exertion
  • Arrhythmia Patterns (>2.7 million Americans with AFib)

    • Paroxysmal: self-terminating within 7 days
    • Persistent: sustained >7 days requiring intervention
      • Rate control: target <110 bpm for asymptomatic patients
      • Rhythm control: cardioversion within 48 hours or anticoagulation

Loading diagram…

📌 Remember: HEART score for chest pain risk stratification - History (0-2 points), ECG (0-2 points), Age (0-2 points), Risk factors (0-2 points), Troponin (0-2 points). Score 0-3 = <2% risk, Score 4-6 = 12-65% risk, Score 7-10 = >65% risk of 30-day MACE.

Diagnostic TestSensitivitySpecificityPositive Predictive ValueNegative Predictive ValueTime to Result
Troponin I>95%>90%Variable>99%<1 hour
ECG70-80%>95%>90%85%<5 minutes
Stress Echo85%80%85%80%45 minutes
Coronary CTA>95%85%Variable>99%30 minutes
BNP90%75%Variable>95%<30 minutes

💡 Master This: Diagnostic pattern recognition combines pretest probability assessment with systematic test interpretation. Bayesian reasoning guides test selection where high pretest probability requires high specificity tests, while low pretest probability needs high sensitivity tests. Understanding test characteristics prevents diagnostic errors and optimizes resource utilization.

Mastering diagnostic patterns creates the foundation for developing evidence-based treatment algorithms that optimize patient outcomes through targeted interventions.


🎯 Diagnostic Pattern Recognition: Decoding the Cardiac Clues

⚕️ Treatment Algorithms: The Therapeutic Precision Matrix

Acute Coronary Syndrome Management

Loading diagram…
  • STEMI Treatment Protocols (door-to-balloon <90 minutes)

    • Primary PCI: >95% reperfusion success with <3% mortality
    • Fibrinolytic therapy: 60-80% reperfusion with 6-7% mortality
      • Contraindications: active bleeding, stroke <3 months, surgery <2 weeks
      • Rescue PCI: indicated if <50% ST resolution at 90 minutes
      • Transfer protocols: door-to-balloon <120 minutes including transport
  • NSTEMI/UA Management (risk-stratified approach)

    • High-risk: TIMI score ≥5 or GRACE score >140
    • Invasive strategy: catheterization within 24 hours
      • Eptifibatide: bolus 180 mcg/kg then 2 mcg/kg/min infusion
      • Bivalirudin: 0.75 mg/kg bolus then 1.75 mg/kg/hr infusion
      • Clopidogrel: 600 mg loading then 75 mg daily
  • Heart Failure Treatment Algorithms (guideline-directed medical therapy)

    • ACE inhibitors: target dose or maximum tolerated
    • Beta-blockers: start low, go slow with target heart rate 60-70 bpm
      • Metoprolol: start 12.5 mg BID, target 200 mg BID
      • Carvedilol: start 3.125 mg BID, target 25-50 mg BID
      • Bisoprolol: start 1.25 mg daily, target 10 mg daily

📌 Remember: MONA-BASH for acute MI management - Morphine (if needed), Oxygen (if SpO2 <90%), Nitroglycerin (avoid if RV infarct), Aspirin (162-325 mg), Beta-blocker (if no contraindications), ACE inhibitor (start within 24 hours), Statin (high-intensity), Heparin (unfractionated or LMWH).

Treatment StrategyTarget PopulationPrimary EndpointNNTMortality BenefitMajor Bleeding Risk
Primary PCISTEMI <12 hoursReperfusion332-3% absolute<1%
Dual AntiplateletACS patientsRecurrent MI671.5% absolute2-4%
ACE InhibitorPost-MI, HFCV death502% absoluteRare
Beta-blockerPost-MISudden death841.2% absoluteRare
High-intensity StatinACSMACE741.4% absolute<0.1%

💡 Master This: Treatment algorithms optimize outcomes through systematic risk-benefit analysis. Number needed to treat (NNT) quantifies therapeutic benefit where lower NNT indicates greater efficacy. Dual antiplatelet therapy prevents 1 recurrent MI for every 67 patients treated but causes major bleeding in 2-4%. Understanding these trade-offs enables personalized treatment decisions.

Treatment algorithm mastery provides the foundation for understanding how multiple cardiac conditions interact and require integrated management approaches.


⚕️ Treatment Algorithms: The Therapeutic Precision Matrix

🌐 Advanced Integration: The Cardiac Pathology Synthesis

Multi-System Cardiac Interactions

  • Cardio-Renal Syndrome (>40% of heart failure patients)

    • Type 1: acute heart failure causing acute kidney injury
    • Type 2: chronic heart failure leading to chronic kidney disease
      • Mechanism: reduced renal perfusion + venous congestion
      • Biomarkers: creatinine rise >0.3 mg/dL within 48 hours
      • Treatment: ultrafiltration removing >500 mL/hour excess fluid
      • Prognosis: doubled mortality when both organs involved
  • Cardio-Oncology Interactions (emerging subspecialty)

    • Anthracycline cardiotoxicity: dose-dependent with >250 mg/m² threshold
    • Trastuzumab-induced cardiomyopathy: reversible in >80% of cases
      • Monitoring: LVEF assessment every 3 months during treatment
      • Prevention: dexrazoxane reduces cardiotoxicity by 65%
      • Management: ACE inhibitors + beta-blockers for LV dysfunction
  • Metabolic-Cardiac Connections (diabetes + CVD)

    • Diabetic cardiomyopathy: independent of coronary artery disease
    • SGLT2 inhibitors: 35% reduction in heart failure hospitalizations
      • Mechanism: natriuresis + improved energetics + reduced inflammation
      • Benefits: evident within 3 months of treatment initiation
Loading diagram…

📌 Remember: CARDIAC multi-system assessment - Cardio-renal (creatinine trends), Arrhythmia burden (Holter monitoring), Respiratory status (BNP levels), Diabetic control (HbA1c targets), Inflammatory markers (CRP, ESR), Anticoagulation needs (bleeding vs thrombosis risk), Cancer therapy effects (cardiotoxicity screening).

Integration DomainKey BiomarkerMonitoring FrequencyIntervention ThresholdOutcome ImprovementCost-Effectiveness
Cardio-RenalCreatinineEvery 48 hours>0.3 mg/dL rise25% mortality reductionHigh
Cardio-OncologyTroponinEvery 3 months>ULN elevation80% reversibilityModerate
Diabetes-CVDHbA1cEvery 3 months>7% target35% HF reductionVery High
Heart-LungBNPMonthly>400 pg/mL30% readmission reductionHigh
InflammationCRPAs indicated>3 mg/LVariableLow

💡 Master This: Advanced cardiac pathology requires systems thinking where single interventions affect multiple organ systems. SGLT2 inhibitors demonstrate pleiotropic effects beyond glucose control, providing cardiovascular benefits through natriuresis, improved cardiac energetics, and reduced inflammation. Understanding these multi-system interactions enables precision medicine approaches that optimize outcomes across multiple domains simultaneously.

This advanced integration framework establishes the foundation for developing rapid mastery tools that synthesize complex cardiac pathology into actionable clinical knowledge.


🌐 Advanced Integration: The Cardiac Pathology Synthesis

🎯 Cardiac Pathology Mastery: The Clinical Command Center

Essential Clinical Arsenal

  • Rapid Assessment Framework (<5 minute evaluation)

    • History: chest pain characteristics, timing, triggers, relief factors
    • Physical: vital signs, heart sounds, peripheral perfusion, JVD assessment
      • S3 gallop: >90% sensitivity for heart failure with EF <40%
      • S4 gallop: indicates diastolic dysfunction with preserved EF
      • Murmur grading: Grade 4-6 indicates severe valvular disease
      • Pulsus paradoxus: >20 mmHg suggests cardiac tamponade
  • Diagnostic Hierarchy (evidence-based prioritization)

    • ECG: first-line for acute presentations with <2 minute interpretation
    • Troponin: rule-out MI with high-sensitivity assays at 0 and 1 hour
      • Echocardiogram: structural assessment with real-time hemodynamics
      • Advanced imaging: cardiac MRI for tissue characterization
      • Invasive testing: catheterization for definitive coronary assessment
  • Treatment Prioritization Matrix (time-sensitive interventions)

    • Immediate (<15 minutes): STEMI, cardiogenic shock, cardiac arrest
    • Urgent (<2 hours): NSTEMI, acute heart failure, unstable arrhythmias
      • Semi-urgent (<24 hours): stable angina, chronic heart failure
      • Elective (days-weeks): routine follow-up, risk factor modification
Loading diagram…

📌 Remember: CARDIAC mastery checklist - Clinical assessment (history + physical), Acute interventions (time-sensitive), Risk stratification (evidence-based), Diagnostic testing (systematic), Imaging interpretation (structured), Advanced therapies (guideline-directed), Continuous monitoring (outcome-focused). Each element has specific timeframes and measurable endpoints.

Clinical ScenarioTime to DiagnosisKey Diagnostic TestTreatment WindowSuccess RateMortality Reduction
STEMI<10 minutesECG<90 minutes>95%50% relative
Cardiogenic Shock<30 minutesEcho + Swan-Ganz<60 minutesVariable30% absolute
Acute Heart Failure<60 minutesBNP + Echo<4 hours>90%20% relative
Cardiac Tamponade<15 minutesEcho<30 minutes>95%Life-saving
Aortic Dissection<30 minutesCT Angiography<2 hours>90%40% relative

💡 Master This: Cardiac pathology mastery requires integration of anatomical knowledge, pathophysiological understanding, clinical correlation, and therapeutic expertise. Expert practitioners develop mental models that enable rapid pattern recognition, accurate risk stratification, and optimal treatment selection. This cognitive framework transforms complex clinical scenarios into manageable decision trees with predictable outcomes and measurable success rates.

🎯 Cardiac Pathology Mastery: The Clinical Command Center

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

Scan to download
UNLOCK FREE ACCESS

All Lessons (10)

Practice Questions: Cardiac Pathology

  1. 1. A 55-year-old woman has had predictable chest pain on climbing four flights of stairs or jogging for three months. Each episode resolves within five minutes of rest. Her mother had a myocardial infarction at 50 years. What is the most likely diagnosis?

    • A. Supraventricular tachycardia
    • B. Stable angina pectoris
    • C. Myocardial infarction
    • D. Prinzmetal angina pectoris
    Show answer

    Answer: B. Stable angina pectoris

    Stable angina pectoris - Stable angina pectoris causes predictable chest pain precipitated by exertion, such as climbing stairs or jogging, because fixed coronary stenosis limits flow when oxygen demand rises. - This represents a demand-supply mismatch: myocardial perfusion is adequate at rest but insufficient during exertion, with symptoms typically relieved by rest or sublingual nitroglycerin. Supraventricular tachycardia - Supraventricular tachycardia typically causes abrupt episodes of rapid palpitations, sometimes with chest discomfort; the supplied predictable exertional pain pattern more strongly supports stable angina. Myocardial infarction - Myocardial infarction is acute myocardial injury with evidence of ischemia and may occur with or without acute coronary occlusion; when chest pain occurs, it is typically prolonged rather than predictably limited to a reproducible exertional threshold. - Infarction is not characterized by this patient’s reproducible exertional pattern with predictable onset; stable symptoms instead suggest fixed stenosis without acute infarction. Prinzmetal angina pectoris - Prinzmetal angina pectoris results from transient coronary vasospasm and characteristically occurs at rest, often during the early morning hours, rather than after predictable exertion. - The patient’s symptoms are consistently triggered by increased physical demand, supporting fixed atherosclerotic obstruction rather than episodic vasospasm.

  2. 2. Water hammer pulse is seen in which of the following conditions?

    • A. Mitral regurgitation
    • B. Mitral stenosis
    • C. Aortic regurgitation
    • D. Aortic stenosis
    Show answer

    Answer: C. Aortic regurgitation

    Aortic regurgitation - In aortic regurgitation, the left ventricle ejects an increased stroke volume because it pumps both normal blood and regurgitated blood. - During diastole, rapid runoff into the left ventricle causes a marked fall in diastolic pressure, producing a wide pulse pressure and collapsing pulse. Mitral regurgitation - Mitral regurgitation generally produces a normal or slightly reduced pulse volume rather than a rapidly collapsing pulse. - The characteristic wide pulse pressure and marked diastolic pressure fall of a water hammer pulse are not typical of isolated mitral regurgitation. Mitral stenosis - Mitral stenosis generally produces a low-volume pulse because left ventricular filling is reduced. It does not characteristically produce the rapid rise and collapse of a water hammer pulse. Aortic stenosis - Aortic stenosis restricts left ventricular outflow, reducing the volume and speed of the arterial pulse. - It classically causes pulsus parvus et tardus, a small-volume, slow-rising pulse, rather than a forceful rapid upstroke with sudden collapse.

  3. 3. Which of the following is NOT a typical chest radiographic feature of unrepaired tetralogy of Fallot with reduced pulmonary blood flow?

    • A. Boot-shaped cardiac silhouette
    • B. Pulmonary vascular plethora
    • C. Upturned cardiac apex
    • D. Right-sided aortic arch
    Show answer

    Answer: B. Pulmonary vascular plethora

    Pulmonary vascular plethora - Pulmonary vascular plethora indicates increased pulmonary vascular markings and increased pulmonary blood flow, which is not typical of Tetralogy of Fallot. - Tetralogy of Fallot usually causes pulmonary oligemia because pulmonary outflow obstruction reduces blood flow to the lungs; therefore, plethora is the exception. Boot-shaped cardiac silhouette - A boot-shaped cardiac silhouette is a classic CXR finding in Tetralogy of Fallot, produced by right ventricular hypertrophy and an upturned cardiac apex. - This finding supports Tetralogy of Fallot, which causes pulmonary outflow obstruction and reduced pulmonary blood flow in a cyanotic neonate. Upturned cardiac apex - Upturned cardiac apex is a classic radiographic manifestation of right ventricular hypertrophy in tetralogy of Fallot and contributes to the boot-shaped cardiac silhouette. Right-sided aortic arch - A right-sided aortic arch is a recognized associated anomaly in Tetralogy of Fallot and occurs in approximately 25% of affected patients. - It is not present in every patient, but its association with Tetralogy of Fallot makes it a possible CXR finding rather than the exception.

  4. 4. Which condition best explains the ECG changes shown?

    • A. Digoxin toxicity
    • B. Digoxin effect
    • C. Myocardial ischemia
    • D. Myocardial injury
    Show answer

    Answer: B. Digoxin effect

    Digoxin effect - Digoxin characteristically causes downward-sloping ST-segment depression with a sagging or scooped appearance, classically described as a Salvador Dalí mustache. - This repolarization effect results from digoxin-induced shortening of the QT interval and may occur without drug toxicity or other clinical abnormalities. Myocardial injury - Myocardial injury is defined by elevated cardiac troponin and may occur with or without ECG abnormalities; it cannot be diagnosed from ST-segment morphology alone. - The characteristic scooped ST-segment depression favors a digoxin effect rather than myocardial injury, which is not identified by this specific repolarization pattern. Digoxin toxicity - Digoxin toxicity can produce altered ST-T morphology, but it usually causes associated arrhythmias such as ventricular premature beats, bradycardia, or atrioventricular block. - An isolated scooped ST depression indicates digoxin effect but does not establish toxicity without clinical features, arrhythmias, or other supporting evidence. Myocardial ischemia - Myocardial ischemia may cause horizontal or downsloping ST-segment depression, often accompanied by T-wave inversion, but typically lacks the distinctive scooped contour. - The described ST morphology is therefore more consistent with digoxin effect than with ischemic repolarization changes.

  5. 5. Which molecular marker characterizes the leukemia primarily treated with all-trans retinoic acid?

    • A. BCR-ABL1
    • B. CEBPA
    • C. PML-RARA
    • D. CMYC
    Show answer

    Answer: C. PML-RARA

    PML-RARA - PML-RARA is the defining fusion gene of acute promyelocytic leukemia, the malignancy for which all-trans retinoic acid is a cornerstone treatment. - ATRA overcomes the PML-RARA-mediated maturation block by inducing differentiation of leukemic promyelocytes. BCR-ABL1 - BCR-ABL1 characterizes chronic myeloid leukemia and some acute lymphoblastic leukemias, rather than the tumor primarily treated with ATRA. - BCR-ABL1-positive leukemias are primarily treated with tyrosine kinase inhibitors, such as imatinib, not all-trans retinoic acid. CEBPA - CEBPA mutations occur in a subset of acute myeloid leukemias and may be associated with favorable prognosis, but they do not define ATRA-responsive disease. - Although ATRA has roles in some AML contexts, its primary indication here is the PML-RARA fusion, not AML with isolated CEBPA mutations. CMYC - CMYC dysregulation is implicated in cancers such as Burkitt lymphoma and some acute myeloid leukemias, but it does not identify the primary ATRA-treated tumor. - There is no direct therapeutic role for ATRA specifically targeting tumors driven by CMYC overexpression.

  6. 6. In an infant with congestive heart failure, which is the most reliable clinical sign of systemic venous congestion?

    • A. Pedal edema
    • B. Raised JVP
    • C. Basal crackles
    • D. Hepatomegaly
    Show answer

    Answer: D. Hepatomegaly

    Hepatomegaly - Hepatomegaly is a crucial sign of pediatric CHF because hepatic venous congestion produces enlargement of the compressible liver. - The liver can accommodate substantial increases in blood volume, allowing hepatomegaly to become apparent before other signs of systemic venous congestion. Raised JVP - Raised JVP can indicate systemic venous congestion in older children with CHF, but it is difficult to assess reliably in infants and young children because of their short necks and limited cooperation. - Compared with hepatomegaly, raised JVP is less sensitive and less practical as a diagnostic sign across pediatric age groups, particularly in younger children. Basal crackles - Basal crackles indicate pulmonary edema from pulmonary venous congestion and are therefore more suggestive of left-sided heart failure. - Although crepitations may occur in CHF, hepatomegaly is a more consistent and often earlier finding across different forms of pediatric heart failure. Pedal edema - Pedal edema is less common in pediatric CHF, especially in infants and toddlers, than in adults with systemic venous congestion. - Shorter hydrostatic columns and prolonged supine positioning reduce dependent edema, making pedal swelling less prominent than hepatomegaly.

  7. 7. Destination therapy is indicated in which of the following conditions?

    • A. End-stage heart failure
    • B. Acute anterior myocardial infarction
    • C. Cardiac arrhythmia
    • D. Infective endocarditis
    Show answer

    Answer: A. End-stage heart failure

    End-stage heart failure - Destination therapy is permanent LVAD support for patients with end-stage (Stage D) heart failure who remain symptomatic despite maximal medical therapy. - In severe congestive heart failure, LVAD support can improve systemic perfusion, survival, and quality of life when heart transplantation is unsuitable because of age or comorbidities. Acute anterior myocardial infarction - Acute anterior myocardial infarction is treated acutely with reperfusion, such as percutaneous coronary intervention or thrombolysis, rather than permanent LVAD implantation. - Although an infarction may cause subsequent heart failure, destination therapy is not the acute treatment for myocardial injury or coronary occlusion. Cardiac arrhythmia - Arrhythmias are generally managed with anti-arrhythmic drugs, cardioversion, or an implantable cardioverter-defibrillator, depending on the rhythm and risk. - An arrhythmia alone does not usually cause the refractory pump failure required for destination LVAD therapy; mechanical support is not its standard definitive treatment. Infective endocarditis - Infective endocarditis requires prolonged antimicrobial therapy and, when indicated, valve replacement surgery to eradicate infection and correct structural damage. - Active infection is an important contraindication to LVAD implantation, so endocarditis is not an indication for destination therapy.

  8. 8. The thyroid scan shown below exhibits a pattern that is most consistent with which of the following disorders?

    • A. Papillary thyroid carcinoma
    • B. Graves' hyperthyroidism
    • C. Hypersecreting adenoma
    • D. Lateral aberrant thyroid
    Show answer

    Answer: C. Hypersecreting adenoma

    Hypersecreting adenoma - A hypersecreting adenoma produces thyroid hormone autonomously and therefore appears as a focal hot nodule with increased tracer uptake. - Excess hormone suppresses TSH secretion, causing reduced uptake in the remaining thyroid tissue and distinguishing this pattern from diffuse thyroid overactivity. Papillary thyroid carcinoma - Papillary carcinoma usually appears as a cold nodule on thyroid scintigraphy because malignant cells generally concentrate iodine less efficiently than normal thyroid tissue. - Although it is the most common thyroid cancer, papillary carcinoma is rarely associated with increased tracer uptake, unlike the described focal hyperfunctioning pattern. Lateral aberrant thyroid - A lateral aberrant thyroid generally refers to thyroid tissue or metastatic thyroid carcinoma in a cervical lymph node, producing uptake outside the thyroid gland. - It would not explain a focal hot nodule within the thyroid with suppression of the surrounding gland, which indicates autonomous intrathyroidal function. Graves' hyperthyroidism - Graves' disease causes generalized stimulation of thyroid follicular cells by autoantibodies, producing diffuse increased uptake throughout the gland. - The expected scan is a uniformly active thyroid, not a single hot focus with suppressed uptake in the remaining tissue.

  9. 9. Assertion: Myocarditis is seen as a complication in faucial diphtheria. Reason: It is due to the exotoxin produced by Corynebacterium diphtheriae. Which option correctly describes the truth of these statements and their relationship?

    • A. Assertion is true; reason is false and does not explain the assertion
    • B. Assertion is false; reason is true but does not explain the assertion
    • C. Assertion is true; reason is true but does not explain the assertion
    • D. Assertion is true; reason is true and explains the assertion
    Show answer

    Answer: D. Assertion is true; reason is true and explains the assertion

    Assertion is true; reason is true and explains the assertion - Myocarditis is a recognized complication of faucial diphtheria. The exotoxin produced by Corynebacterium diphtheriae causes myocardial injury, directly explaining the assertion. Assertion is true; reason is true but does not explain the assertion - Both statements are true, but the reason directly explains why myocarditis occurs; therefore, this option is incorrect. Assertion is false; reason is true but does not explain the assertion - The assertion is not false: myocarditis is a well-established complication of faucial diphtheria. The reason is true and directly explains the assertion. Assertion is true; reason is false and does not explain the assertion - The reason is not false: diphtheria exotoxin causes myocardial injury and directly explains the occurrence of myocarditis.

  10. 10. Digitalis is used in mitral stenosis to control the ventricular rate when the patient develops which condition?

    • A. Ventricular tachycardia
    • B. Atrial fibrillation
    • C. Multifocal atrial tachycardia
    • D. Sinus tachycardia
    Show answer

    Answer: B. Atrial fibrillation

    Atrial fibrillation is the indication described: digitalis increases vagal influence and AV nodal refractoriness, reducing the ventricular response. Ventricular tachycardia originates below the AV node and is not treated by digitalis-mediated AV nodal slowing. Multifocal atrial tachycardia is managed by correcting precipitating factors and using appropriate rate-control agents; digitalis is not effective treatment. Sinus tachycardia requires treatment of its cause, and digitalis is not the indicated rate-control treatment for mitral stenosis in sinus rhythm.

Flashcards: Cardiac Pathology

  1. 1. _____, secondary to rheumatic fever, is characterized by small inflammatory vegetations along valvular lines of closure, which cause _____

    Show answer

    Endocarditis · regurgitation

  2. 2. In rheumatic heart disease, subendocardial lesions may induce irregular thickenings called

    Show answer

    McCallum plaques

  3. 3. _____ cardiomyopathy may be caused by _____, which is a thick fibroelastic tissue in the endocardium; most commonly affects _____

    Show answer

    Restrictive · endocardial fibroelastosis · young children

  4. 4. The hyaline, eosinophilic deposits seen on the biopsy point to a diagnosis of cardiac amyloidosis, which most commonly leads to  cardiomyopathy.

    Show answer

    restrictive

  5. 5. On biopsy of a heart with myocarditis, a _____ infiltrate with _____ necrosis is highly indicative of viral myocarditis

    Show answer

    lymphocytic · focal

  6. 6. One complication of atherosclerosis is _____, which may result from plaque rupture with _____ of the coronary artery

    Show answer

    myocardial infarction · thrombosis

  7. 7. The hyaline, eosinophilic deposits seen on the biopsy point to a diagnosis of cardiac amyloidosis, which most commonly leads to _____ cardiomyopathy.

    Show answer

    restrictive

  8. 8. _____ cardiomyopathy is characterized by myofibrillar hypertrophy with _____ and fibrosis on biopsy

    Show answer

    Hypertrophic · disarray

  9. 9. Aschoff's bodies in rheumatic heart disease shows _____ necrosis.

    Show answer

    fibrinoid

  10. 10. _____ disease is a glycogen storage disease associated with _____ cardiomyopathy

    Show answer

    Pompe · hypertrophic

Everything you need for Indian Medical PG prep

Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.

GET STARTED FOR FREE
75% OFFLimited time offer
GET 75% OFF